메뉴 건너뛰기
The Lancet
Volumn 381, Issue 9877, 2013, Pages 1537-
Regorafenib for metastatic colorectal cancer
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; REGORAFENIB; ANTINEOPLASTIC AGENT; CARBANILAMIDE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;
EID: 84877286724     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60976-9     Document Type: Letter
Times cited : (10)
References (5)
  • 1
    • 84872921660 scopus 로고    scopus 로고
    • Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial
    • A Grothey, E Van Cutsem, A Sobrero et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Lancet 381 2013 303 312
    • (2013) Lancet , vol.381 , pp. 303-312
    • Grothey, A.1    Van Cutsem, E.2    Sobrero, A.3
  • 2
    • 84872916615 scopus 로고    scopus 로고
    • Evaluation of regorafenib in colorectal cancer and GIST
    • T Waddell, D Cunningham Evaluation of regorafenib in colorectal cancer and GIST Lancet 381 2013 273 275
    • (2013) Lancet , vol.381 , pp. 273-275
    • Waddell, T.1    Cunningham, D.2
  • 3
    • 70349939382 scopus 로고    scopus 로고
    • Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer
    • S Siena, A Sartore-Bianchi, F Di Nicolantonio, J Balfour, A Bardelli Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer J Natl Cancer Inst 101 2009 1308 1324
    • (2009) J Natl Cancer Inst , vol.101 , pp. 1308-1324
    • Siena, S.1    Sartore-Bianchi, A.2    Di Nicolantonio, F.3    Balfour, J.4    Bardelli, A.5
  • 4
    • 72249083700 scopus 로고    scopus 로고
    • Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases
    • YS Chun, JN Vauthey, P Boonsirikamchai et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases JAMA 302 2009 2338 2344
    • (2009) JAMA , vol.302 , pp. 2338-2344
    • Chun, Y.S.1    Vauthey, J.N.2    Boonsirikamchai, P.3
  • 5
    • 84874691266 scopus 로고    scopus 로고
    • Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab
    • R Ricotta, A Vanzulli, M Moroni et al. Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab Clin Colorectal Cancer 12 2013 45 53
    • (2013) Clin Colorectal Cancer , vol.12 , pp. 45-53
    • Ricotta, R.1    Vanzulli, A.2    Moroni, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.